Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iontophoretic S-ketamine for peripheral neuropathic pain
NL-OMON36563Withdrawn
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in Peripheral neuropathic pain (4 arms), sponsored by Noordwest Ziekenhuisgroep. Primary endpoint: Overall pain relief. Planned start Sep 2011; status: withdrawn.
02
Drugs
esketamine
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NL-OMON36563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36563.